CalciMedica, Inc. (CALC): Nasdaq/NYSE listing notice — CalciMedica delisted from Nasdaq, now trading on OTCQB after failing initial listing requirements
CalciMedica, Inc.
Received Nasdaq delisting notice on March 21, 2023 for not meeting initial listing requirements after merger.
Trading suspended March 31, 2023, moved to Pink sheets April 3, 2023.
Upgraded to OTCQB tier on April 26, 2023, providing Real Time Level 2 quotes.
Withdrew Nasdaq appeal on May 1, 2023; Nasdaq to file Form 25 delisting notice.
Company maintains initial listing application on Nasdaq and intends to seek relisting on Nasdaq Capital Market.
CalciMedica, Inc. received a nasdaq delisting notice notice regarding other (rules 5110(a)).
Exchange
nasdaq
Notice
delisting notice
Rules
5110(a)
Exact text from the filing
May 1, 2023, the Company withdrew its request for an appeal of the Staff’s Delist Determination and received a notice from Nasdaq stating that Nasdaq will file a Form 25 Notification of Delisting with the SEC when all internal procedural periods have run. The Company has an initial listing application on file for the listing of the Company’s shares of common stock on Nasdaq and the Company intends to continue to work diligently to satisfy the initial listing requirements and to seek a listing as soon as possible on the Nasdaq Capital Market.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.